The MHC2TA - 168A (13) Yazdani Biuki, Babak a Brickmann, Kerstin a Wohlfahrt, Klaus a Mueller, Thomas a März, Winfried a Renner, Wilfried a Gutjahr, Manuela a Langsenlehner, Uwe a Krippl, Peter a Wascher, Thomas C a Paulweber, Bernhard b Graninger, Winfried a Brezinschek, Hans Peter a a MEDICAL UNIVERSITY OF GRAZ (Austria) b MEDICAL UNIVERSITY OF VIENNA (Austria)

Arthritis Research and Therapy

Volumn 8, Issue 4, 2006, Pages

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

AGED; AUSTRIA; CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; RHEUMATOID ARTHRITIS; SWEDEN;

ADENINE; AGED; ARTHRITIS, RHEUMATOID; AUSTRIA; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GUANINE; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; SWEDEN; TRANS-ACTIVATORS;

EID: 34247550761     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1974     Document Type: Article

References (20)

1. Arend WP: The pathophysiology and treatment of rheumatoid arthritis Arthritis Rheum 1997, 40:595-597.
2. Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Cantagrel A, Chary-Valckenaere I, Euller-Ziegler L, Flipo RM, et al. Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005, 64:1427-1430.
3. MacGregor AJ, Bamber S, Silman AJ: A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol 1994, 21:1420-1426.
4. Deighton CM, Walker DJ, Griffiths ID, Roberts DF: The contribution of HLA to rheumatoid arthritis. Clin Genet 1989, 36:178-182.
5. Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI: HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA 1989, 86:10049-10053.
6. Weyand CM, Hicok KC, Conn DL, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992, 117:801-806.
7. MacGregor AJ, Bamber S, Carthy D, Vencovsky J, Mageed RA, Ollier WE, Silman AJ: Heterogeneity of disease phenotype in monozygotic twins concordant for rheumatoid arthritis. Br J Rheumatol 1995, 34 215-220.
8. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, Wolfe F, Kastner DL, Alfredsson L, Altshuler D, et al.: Replication of putative candidate-gene associations with rheumatoid arthritis in>4,000 samples from North America and Sweden: Association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 2005, 77:1044-1060.
9. Johansson M, Arlestig L, Hallmans G, Rantapaa-Dahlqvist S: PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther 2006, 8:R19.
10. Barton A, Ollier W: Genetic approaches to the investigation of rheumatoid arthritis. Curr Opin Rheumatol 2002, 14 260-269.
11. Barton A, Eyre S, Bowes J, Ho P, John S, Worthington J: Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients. Arthritis Rheum 2005, 52:752-758.
12. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Borjesson O, Lindgren CM, et al.: MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005, 37:486-494.
13. Friese MA, Jones EY, Fugger L: MHC II molecules in inflammatory diseases: Interplay of qualities and quantities. Trends Immunol 2005, 26:559-561.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
15. Strohmer B, Pichler M, Iglseder B, Paulweber B: Relationship of QT interval duration with carotid intima media thickness in a clinically healthy population undergoing cardiovascular risk screening. J Intern Med 2005, 257:238-246.
16. Iglseder B, Mackevics V, Stadlmayer A, Tasch G, Ladurner G, Paulweber B: Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: Data from the SAPHIR Study. Stroke 2005, 36:2577-2582.
17. Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 1949, 140:659-662.
18. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Jarvela I: Identification of a variant associated with adult-type hypolactasia Nat Genet 2002, 30:233-237.
19. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, et al.: Geographic distribution of the 20210 G to A prothrombinvariant. Thromb Haemost 1998, 79:706-708.
20. Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT: Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int J Immunogenet 2006, 33:59-61.